This Company Just Got $54 Million to Develop Rare Cancer Drugs
geralt / Pixabay

This Company Just Got $54 Million to Develop Rare Cancer Drugs

According to a story from crainsnewyork.com, the biotechnology company Gotham Therapeutics has received financing to the tune of $54 million so that it can begin developing drugs to treat rare…

Continue Reading This Company Just Got $54 Million to Develop Rare Cancer Drugs

A Trove of Brain Cancer Data Just Became Available to Researchers

According to a story from healthnewsdigest.com, an important source of data related to brain cancer has just become widely available to global researchers. This dataset was supported by Georgetown University,…

Continue Reading A Trove of Brain Cancer Data Just Became Available to Researchers
Research Suggests That PARP Inhibitors Have More Potential Than Previously Thought
FotoshopTofs / Pixabay

Research Suggests That PARP Inhibitors Have More Potential Than Previously Thought

According to a story from Fierce Biotech, recent research is highlighting the possibility that PARP inhibitors, a type of targeted therapy that it mostly used to treat breast cancer and…

Continue Reading Research Suggests That PARP Inhibitors Have More Potential Than Previously Thought
Treatment for Glaucoma and Altitude Sickness Could Slow the Progression of Glioblastoma
Pexels / Pixabay

Treatment for Glaucoma and Altitude Sickness Could Slow the Progression of Glioblastoma

According to a story from EurekAlert!, researchers have found that the drug Diamox, which is used to treat a variety of illnesses and conditions such as altitude sickness, glaucoma, epilepsy,…

Continue Reading Treatment for Glaucoma and Altitude Sickness Could Slow the Progression of Glioblastoma
New Computational Framework Could Increase the Effectiveness of Cancer Treatment
Source: Pixabay

New Computational Framework Could Increase the Effectiveness of Cancer Treatment

According to a story from bioengineer.org, a group of scientists working at the Columbia University Irving Medical Center (CUIMC) have managed to develop a computational model that could potentially make highly…

Continue Reading New Computational Framework Could Increase the Effectiveness of Cancer Treatment
Researchers Highlight a Potential New Treatment Route For Glioblastoma
tiburi / Pixabay

Researchers Highlight a Potential New Treatment Route For Glioblastoma

According to a story from news-medical.net, a group of scientists from the Cincinnati Children's Cancer and Blood Diseases Institute have recently published a study in the journal Nature Cell Biology. This…

Continue Reading Researchers Highlight a Potential New Treatment Route For Glioblastoma
A Phase II Trial for a Personalized Ovarian Cancer ‘Vaccine’ Has Begun
pandoraferrari / Pixabay

A Phase II Trial for a Personalized Ovarian Cancer ‘Vaccine’ Has Begun

According to a story from PR Newswire, the drug development company AIVITA Biomedical recently announced that the first patient in its Phase II clinical trial has been randomized. This is…

Continue Reading A Phase II Trial for a Personalized Ovarian Cancer ‘Vaccine’ Has Begun
VCU Researchers Make Major Advancements in Glioblastoma Research
Source: Pixabay

VCU Researchers Make Major Advancements in Glioblastoma Research

According to EurekAlert!, a study at Virginia Commonwealth University has potentially pinpointed the so called "Achilles heal" of a certain type of deadly brain cancer: glioblastoma multiforme. Glioblastoma, or glioblastoma…

Continue Reading VCU Researchers Make Major Advancements in Glioblastoma Research
A Potential Treatment For Glioblastoma Has Shown Promising Interim Results in a Clinical Trial
Source: Pixabay

A Potential Treatment For Glioblastoma Has Shown Promising Interim Results in a Clinical Trial

A Phase II trial of the experimental treatment SurVaxM, under development by the biotechnology company MimiVax LLC, has produced encouraging interim results for treating patients with newly diagnosed glioblastoma. The…

Continue Reading A Potential Treatment For Glioblastoma Has Shown Promising Interim Results in a Clinical Trial
Researchers Receive Funding in Order to Study Difficult to Treat Cancers
source: pixabay.com

Researchers Receive Funding in Order to Study Difficult to Treat Cancers

According to a story from pressreleasepoint.com, a group of scientists at the University of Birmingham have a received funding to the tune of £3 million in order to conduct research on…

Continue Reading Researchers Receive Funding in Order to Study Difficult to Treat Cancers
Close Menu